DIN 02304678 · ended May 13, 2024 · Delay in shipping of the drug.
Resolved
APO-ALFUZOSIN
10MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02315866 · ended Mar 21, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 22 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Alfuzosin. Health Canada has 22 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Alfuzosin is classified under “DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY” (ATC G04CA).
Recent changes
Oct 27, 2026
Shortage resolved
Oct 2, 2026
Shortage resolved
Sep 11, 2026
Estimated end date pushed back : Sep 18, 2026 → Oct 2, 2026
Jul 30, 2026
New report filed
Common questions
What is Alfuzosin used for?
An alpha blocker used to relieve urinary symptoms of an enlarged prostate.
When will Alfuzosin be back in stock in Canada?
Alfuzosin has no active shortage; supply is normal per Health Canada reports.
Why is Alfuzosin in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.